Vogt-Koyanagi-Harada syndrome: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
No edit summary
 
Line 1: Line 1:
{{Infobox_Disease |
__NOTOC__
  Name          = {{PAGENAME}} |
  Image          = VKHS.jpg|
  Caption        = |
  DiseasesDB    = 13983 |
  ICD10          = {{ICD10|H|20|8|h|15}} |
  ICD9          = {{ICD9|364.24}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = derm |
  eMedicineTopic = 739 |
  MeshID        = D014607 |
}}
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}


==Overview==
'''Vogt–Koyanagi–Harada syndrome (VKH syndrome)''' is an uncommon multisystem disease of presumed autoimmune etiology that is characterized by chronic, bilateral, diffuse, granulomatous [[uveitis]] with accompanying dermatologic, neurologic, and auditory involvement.  VKH syndrome is named for ophthalmologists Alfred Vogt from Switzerland and Yoshizo Koyanagi and Einosuke Harada from Japan.<ref>A Vogt. Frühzeitiges Ergrauen der Zilien und Bemerkungen über den sogenannten plötzlichen Eintritt dieser Veränderung. Klinische Monatsblätter für Augenheilkunde, Stuttgart, 1906, 44: 228-242.</ref><ref>Y. Koyanagi. Dysakusis, Alopecie und Poliosis bei schwerer Uveitis nicht traumatischen Ursprungs. Klinische Monatsblätter für Augenheilkunde, Stuttgart, 1929, 82: 194-211.</ref><ref>E. Harada. Clinical study of nonsuppurative choroiditis. A report of acute diffuse choroiditis. Acta Societatis ophthalmologicae Japonicae, 1926, 30: 356.</ref>
==Pathophysiology==
VKH syndrome is an immune-mediated disease. The mechanism of the disease is thought to be [[T helper cell]] mediated autoimmune attack of [[melanocyte]]s in the skin, [[uvea]], [[central nervous system]] and [[inner ear]]. A new T-cell subset [[T helper 17 cell|Th17]] may play an important role in the initiation and maintenance of inflammatory disease when stimulated by the interleukin [[Interleukin 23|IL-23]], thus producing [[Interleukin 17|IL-17]].<ref>{{cite journal|last=Bordaberry|first=MF|title=Vogt-Koyanagi-Harada disease: diagnosis and treatments update.|journal=Current opinion in ophthalmology|date=Nov 2010|volume=21|issue=6|pages=430–5|pmid=20829689|doi=10.1097/ICU.0b013e32833eb78c}}</ref>
There is a higher rate of VKH syndrome in people of Asian, Latin, and Mediterranean descent
==Clinical Presentation==


__NOTOC__
{| style="float: right;"
==Overview==
| [[File:VKHS.jpg|thumb|250px|Dermatologic manifestation of VKH]]
|}
 
There are 4 stages of VKH syndrome: prodromal, acute uveitic, convalescent, and chronic recurrent.
 
* The prodromal stage is marked by flu-like symptoms. Patients present with headache, nausea, [[meningism]], dysacusia (discomfort caused by loud noises or a distortion in the quality of the sounds being heard) and [[tinnitus]].
* The acute uveitic stage is heralded by the onset of [[vision loss|blurring of vision]] in both eyes and is marked by bilateral granulomatous anterior uveitis, variable degree of vitritis, thickening of the posterior choroid with elevation of the peripapillary retinal choroidal layer, hyperemia and edema of the optic nerve, and multiple serous retinal detachments.
* The convalescent stage occurs several weeks later and is marked by gradual depigmentation of the choroid, resulting in the classic orange-red discoloration, or sunset glow [[fundus (eye)|fundus]] appearance. Skin changes, including [[vitiligo]], alopecia and poliosis typically appear during this stage.
* The chronic recurrent stage is marked by repeated bouts of uveitis.
 
==Diagnosis==


'''Vogt-Koyanagi-Harada syndrome (VKH syndrome)''' is a condition seen in humans and dogs involving various melanocyte-containing organs, characterized by [[uveitis]] (inflammation of the inside of the [[eye]]), poliosis (whitening of hair), [[vitiligo]] (loss of pigment in the skin), and [[meningitis]], although dogs with this syndrome rarely develop meningitis.  It is also known as '''uveodermatologic syndrome'''.  VKH syndrome is an immune-mediated disease.
The diagnosis of VKH syndrome is made by [[ophthalmologist]] or [[optometrist]] based on clinical presentation. Imaging techniques such as [[fluorescein angiography]] are used to confirm diagnosis.


The mechanism of the disease is thought to be [[T helper cell]] mediated autoimmune attack of [[melanocyte]]s in the skin and [[uvea]] of dogs and humans, and in the [[central nervous system]] and [[inner ear]] of humans.<ref>{{cite journal |author=Sigle K, McLellan G, Haynes J, Myers R, Betts D |title=Unilateral uveitis in a dog with uveodermatologic syndrome |journal=J Am Vet Med Assoc |volume=228 |issue=4 |pages=543-8 |year=2006 |pmid=16478427}}</ref>
==Treatment==


In humans there is a higher rate of VKH syndrome in people of Asian, Latin, and Mediterranean descent.<ref name=Gelatt_1999>{{cite book|author=Gelatt, Kirk N. (ed.)|title=Veterinary Ophthalmology|edition=3rd ed.|publisher=Lippincott, Williams & Wilkins|year=1999|id=ISBN 0-683-30076-8}}</ref>
The acute stage of VKH syndrome is exquisitely responsive to early and aggressive treatment with topical, periocular and systemic [[corticosteroids]] and [[cycloplegic]] agents.


==References==
==References==
{{reflist|2}}
{{reflist|2}}


{{eye pathology}}
==External Links==
 
 
[[Category:Ophthalmology]]


*[http://vogtkoyanagiharadasyndrome.weebly.com/ VKH Story]


[[ja:原田病]]
{{Eye pathology}}
[[pl:Zespół Vogta, Koyanagiego i Harady]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 00:43, 26 June 2014

WikiDoc Resources for Vogt-Koyanagi-Harada syndrome

Articles

Most recent articles on Vogt-Koyanagi-Harada syndrome

Most cited articles on Vogt-Koyanagi-Harada syndrome

Review articles on Vogt-Koyanagi-Harada syndrome

Articles on Vogt-Koyanagi-Harada syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Vogt-Koyanagi-Harada syndrome

Images of Vogt-Koyanagi-Harada syndrome

Photos of Vogt-Koyanagi-Harada syndrome

Podcasts & MP3s on Vogt-Koyanagi-Harada syndrome

Videos on Vogt-Koyanagi-Harada syndrome

Evidence Based Medicine

Cochrane Collaboration on Vogt-Koyanagi-Harada syndrome

Bandolier on Vogt-Koyanagi-Harada syndrome

TRIP on Vogt-Koyanagi-Harada syndrome

Clinical Trials

Ongoing Trials on Vogt-Koyanagi-Harada syndrome at Clinical Trials.gov

Trial results on Vogt-Koyanagi-Harada syndrome

Clinical Trials on Vogt-Koyanagi-Harada syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Vogt-Koyanagi-Harada syndrome

NICE Guidance on Vogt-Koyanagi-Harada syndrome

NHS PRODIGY Guidance

FDA on Vogt-Koyanagi-Harada syndrome

CDC on Vogt-Koyanagi-Harada syndrome

Books

Books on Vogt-Koyanagi-Harada syndrome

News

Vogt-Koyanagi-Harada syndrome in the news

Be alerted to news on Vogt-Koyanagi-Harada syndrome

News trends on Vogt-Koyanagi-Harada syndrome

Commentary

Blogs on Vogt-Koyanagi-Harada syndrome

Definitions

Definitions of Vogt-Koyanagi-Harada syndrome

Patient Resources / Community

Patient resources on Vogt-Koyanagi-Harada syndrome

Discussion groups on Vogt-Koyanagi-Harada syndrome

Patient Handouts on Vogt-Koyanagi-Harada syndrome

Directions to Hospitals Treating Vogt-Koyanagi-Harada syndrome

Risk calculators and risk factors for Vogt-Koyanagi-Harada syndrome

Healthcare Provider Resources

Symptoms of Vogt-Koyanagi-Harada syndrome

Causes & Risk Factors for Vogt-Koyanagi-Harada syndrome

Diagnostic studies for Vogt-Koyanagi-Harada syndrome

Treatment of Vogt-Koyanagi-Harada syndrome

Continuing Medical Education (CME)

CME Programs on Vogt-Koyanagi-Harada syndrome

International

Vogt-Koyanagi-Harada syndrome en Espanol

Vogt-Koyanagi-Harada syndrome en Francais

Business

Vogt-Koyanagi-Harada syndrome in the Marketplace

Patents on Vogt-Koyanagi-Harada syndrome

Experimental / Informatics

List of terms related to Vogt-Koyanagi-Harada syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Vogt–Koyanagi–Harada syndrome (VKH syndrome) is an uncommon multisystem disease of presumed autoimmune etiology that is characterized by chronic, bilateral, diffuse, granulomatous uveitis with accompanying dermatologic, neurologic, and auditory involvement. VKH syndrome is named for ophthalmologists Alfred Vogt from Switzerland and Yoshizo Koyanagi and Einosuke Harada from Japan.[1][2][3]

Pathophysiology

VKH syndrome is an immune-mediated disease. The mechanism of the disease is thought to be T helper cell mediated autoimmune attack of melanocytes in the skin, uvea, central nervous system and inner ear. A new T-cell subset Th17 may play an important role in the initiation and maintenance of inflammatory disease when stimulated by the interleukin IL-23, thus producing IL-17.[4]

There is a higher rate of VKH syndrome in people of Asian, Latin, and Mediterranean descent

Clinical Presentation

Dermatologic manifestation of VKH

There are 4 stages of VKH syndrome: prodromal, acute uveitic, convalescent, and chronic recurrent.

  • The prodromal stage is marked by flu-like symptoms. Patients present with headache, nausea, meningism, dysacusia (discomfort caused by loud noises or a distortion in the quality of the sounds being heard) and tinnitus.
  • The acute uveitic stage is heralded by the onset of blurring of vision in both eyes and is marked by bilateral granulomatous anterior uveitis, variable degree of vitritis, thickening of the posterior choroid with elevation of the peripapillary retinal choroidal layer, hyperemia and edema of the optic nerve, and multiple serous retinal detachments.
  • The convalescent stage occurs several weeks later and is marked by gradual depigmentation of the choroid, resulting in the classic orange-red discoloration, or sunset glow fundus appearance. Skin changes, including vitiligo, alopecia and poliosis typically appear during this stage.
  • The chronic recurrent stage is marked by repeated bouts of uveitis.

Diagnosis

The diagnosis of VKH syndrome is made by ophthalmologist or optometrist based on clinical presentation. Imaging techniques such as fluorescein angiography are used to confirm diagnosis.

Treatment

The acute stage of VKH syndrome is exquisitely responsive to early and aggressive treatment with topical, periocular and systemic corticosteroids and cycloplegic agents.

References

  1. A Vogt. Frühzeitiges Ergrauen der Zilien und Bemerkungen über den sogenannten plötzlichen Eintritt dieser Veränderung. Klinische Monatsblätter für Augenheilkunde, Stuttgart, 1906, 44: 228-242.
  2. Y. Koyanagi. Dysakusis, Alopecie und Poliosis bei schwerer Uveitis nicht traumatischen Ursprungs. Klinische Monatsblätter für Augenheilkunde, Stuttgart, 1929, 82: 194-211.
  3. E. Harada. Clinical study of nonsuppurative choroiditis. A report of acute diffuse choroiditis. Acta Societatis ophthalmologicae Japonicae, 1926, 30: 356.
  4. Bordaberry, MF (Nov 2010). "Vogt-Koyanagi-Harada disease: diagnosis and treatments update". Current opinion in ophthalmology. 21 (6): 430–5. doi:10.1097/ICU.0b013e32833eb78c. PMID 20829689.

External Links